Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID ‐19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case‐controlled study from Iran
Soodabeh Shahidsales, Seyed Amir Aledavood, Mona Joudi, et al.
Cancer Reports (2021) Vol. 4, Iss. 5
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
Mona Ariamanesh, Pejman Porouhan, Babak PeyroShabany, et al.
Cancer Investigation (2021) Vol. 40, Iss. 1, pp. 26-34
Open Access | Times Cited: 71
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
Jingjing Lv, Hui Wu, Junjie Xu, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 33
COVID-19 Vaccination in Patients With Malignancy; A Systematic Review and Meta-Analysis of the Efficacy and Safety
Seyed Alireza Javadinia, Kimia Alizadeh, Mohammad-Shafi Mojadadi, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 29
Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study
Ahmad Mehri, Sahar Sotoodeh Ghorbani, Kosar Farhadi-Babadi, et al.
Journal of Intensive Care Medicine (2023) Vol. 38, Iss. 9, pp. 825-837
Open Access | Times Cited: 17
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 25
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
Mehmet Emin Arayıcı, Nazlican Kipcak, Ufuktan Kayacik, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 2915-2928
Open Access | Times Cited: 22
Challenges posed by COVID‐19 in cancer patients: A narrative review
Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, et al.
Cancer Medicine (2021) Vol. 11, Iss. 4, pp. 1119-1135
Open Access | Times Cited: 28
COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
Zhujun Cao, Chenxi Zhang, Shuang Zhao, et al.
Infectious Diseases of Poverty (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 18
Multicenter Study of Antibody Seroprevalence against COVID-19 in Patients Presenting to Iranian Cancer Centers after One Year of the COVID-19 Pandemic
Seyed Alireza Javadinia, Mona Ariamanesh, Maryam Nabavifard, et al.
Cancer Investigation (2021) Vol. 40, Iss. 2, pp. 115-123
Closed Access | Times Cited: 20
Hospital and post-discharge mortality in COVID-19 patients with a preexisting cancer diagnosis in Iran
Monireh Sadat Seyyedsalehi, Marveh Rahmati, Reza Ghalehtaki, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Clinical Characteristics and Outcomes of COVID-19 in 1294 New Cancer Patients: Single-Center, Prospective Cohort Study from Iran
Danial Fazilat‐Panah, Hamid Fallah Tafti, Yavar Rajabzadeh, et al.
Cancer Investigation (2022) Vol. 40, Iss. 6, pp. 505-515
Closed Access | Times Cited: 13
Clinical characteristics, risk factors and outcomes of cancer patients withCOVID‐19: A population‐based study
Jiandong Zhou, Ishan Lakhani, Oscar Hou In Chou, et al.
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 287-296
Open Access | Times Cited: 7
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
COVID-19, Cancer, Vaccines
Seyed Alireza Javadinia, James S. Welsh, Alireza Mosavi Jarrahi
Asian Pacific Journal of Cancer Prevention (2021) Vol. 22, Iss. 10, pp. 3053-3054
Open Access | Times Cited: 10
Psychosomatic Symptoms in Terminally Ill Cancer Patients and Its Relation With Using Complementary and Alternative Medicines: A Cross-Sectional Study in Southeast Iran
Mahlagha Dehghan, Fatemeh Hoseini, Mohammad Ali Zakeri
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
Yash Shah, Stephanie Kjelstrom, Diana Martinez, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3577-3588
Open Access | Times Cited: 6
Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis
Huanhuan Cao, Yufei Huang, Chun-Xiu Zhong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
A case report of mediastinal cavernous hemangioma
Davoud Ouladdameshghi, Mohsen Eshraghi, Alireza Shahhamzeh, et al.
Clinical Case Reports (2021) Vol. 9, Iss. 8
Open Access | Times Cited: 7
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
Tong Li, Rui Song, Jingjie Wang, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 874-884
Open Access | Times Cited: 4
Immunogenicity and Safety of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV) in patients with malignancy
Mona Ariamanesh, Pejman Porouhan, Babak PeyroShabany, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Routine COVID-19 testing may not be necessary for most cancer patients
Ali Ghanbari Motlagh, Fatemeh Elmi, Maisa Yamrali, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Clinical Characteristics and Outcomes in Hospitalized Patients with COVID-19 and Cancer History: A Multicenter Cross-Sectional Study in Southwestern Iran
Javad Zarei, Abbas Sheikhtaheri, Mehrnaz Ahmadi, et al.
International Journal of Hematology-Oncology and Stem Cell Research (2024)
Open Access
Predictive Value of Machine Learning Models in Mortality of Coronavirus Disease 2019 (COVID-19) Pneumonia
Atefeh Rostami, F. Mousavi, Seyed Alireza Javadinia, et al.
International Journal of Computational Intelligence Systems (2024) Vol. 17, Iss. 1
Open Access
Outcomes of Cancer Patients Affected by COVID‐19 in Different Settings: A Retrospective Study in Lebanon
Ahmad El Mahmoud, Elie Jean Karam, Reine Abou Zeidane, et al.
Cancer Reports (2024) Vol. 7, Iss. 11
Open Access
Page 1 - Next Page

Scroll to top